LQDA - NASDAQ

Liquidia Corporation

LQDA·NASDAQ

$55.69

+1.5%

HealthcareBiotechnology

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.95B

EPS-0.8000

P/E Ratio-69.61

Earnings Date08/11/2026

lqda

Other Current Liabilities

Last Annual Value

73.20M

3-Year CAGR

195%

5-Year CAGR

71%

10-Year CAGR

51%

Adjust for Inflation

Liquidia Corporation Competitors Analysis of Other Current Liabilities

LQDA · NASDAQ

Company	Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Liquidia Corporation NASDAQ:LQDA	73.20M	104.6%	87.5%	51.3%
Cogent Biosciences, Inc. NASDAQ:COGT	52.90M	72.5%	70.9%	84.1%
Structure Therapeutics Inc. NASDAQ:GPCR	46.54M	120.8%	88.7%	N/A
Denali Therapeutics Inc. NASDAQ:DNLI	85.47M	58.2%	35.1%	61.7%
89bio, Inc. NASDAQ:ETNB	6.87M	-21.6%	-0.4%	N/A
ImmunityBio, Inc. NASDAQ:IBRX	25.42M	11.6%	9.0%	12.6%
Arcus Biosciences, Inc. NYSE:RCUS	196.00M	71.3%	45.3%	76.1%
Ocular Therapeutix, Inc. NASDAQ:OCUL	25.86M	N/A	N/A	N/A
Agios Pharmaceuticals, Inc. NASDAQ:AGIO	18.20M	-7.8%	-1.7%	-2.9%

Liquidia Corporation Fair Value Envelope

LQDA · NASDAQ

Our analysis suggests that LQDA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $55.69, this represents a potential HIDDEN relative to our calculated worth for Liquidia Corporation.

HIDDEN

Intrinsic Value

Current Price: $55.69

Related Guides

Blog Categories

Continue your LQDA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.